Gene · 170482
Papers2,250
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,250
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastoma. | Front Immunol | 2023 | 37928547 | PubTator, text mining | PubMed |
| An atlas of immune cell transcriptomes in human immunodeficiency virus-infected immunological non-responders identified marker genes that control viral replication. | Chin Med J (Engl) | 2023 | 37914674 | PubTator, text mining | PubMed |
| Cell-type-specific molecular characterization of cells from circulation and kidney in IgA nephropathy with nephrotic syndrome. | Front Immunol | 2023 | 37908345 | PubTator, text mining | PubMed |
| Human Dendritic Cell Subset Isolation by Magnetic Bead Sorting: A Protocol to Efficiently Obtain Pure Populations. | Bio Protoc | 2023 | 37900109 | PubTator, text mining | PubMed |
| Combining Mass Cytometry Data by CyTOFmerge Reveals Additional Cell Phenotypes in the Heterogeneous Ovarian Cancer Tumor Microenvironment: A Pilot Study. | Cancers (Basel) | 2023 | 37894472 | PubTator, text mining | PubMed |
| Effects of Golimumab and Ustekinumab on Circulating Dendritic Cell Migratory Capacity in Inflammatory Bowel Disease. | Biomedicines | 2023 | 37893204 | PubTator, text mining | PubMed |
| T Lymphoblastic Lymphoma Hiding in Mature Plasmacytoid Dendritic Cell Proliferation: A Case Report and Literature Review. | Diagnostics (Basel) | 2023 | 37892069 | PubTator, text mining | PubMed |
| The Potential of Dendritic Cell Subsets in the Development of Personalized Immunotherapy for Cancer Treatment. | Curr Issues Mol Biol | 2023 | 37886952 | PubTator, text mining | PubMed |
| Body mass index-dependent immunological profile changes after left ventricular assist device implantation. | Front Immunol | 2023 | 37885885 | PubTator, text mining | PubMed |
| Recurrent Chemotherapy Treated Indeterminate Dendritic Cell Tumor: Case Report and Literature Review. | Clin Cosmet Investig Dermatol | 2023 | 37881204 | PubTator, text mining | PubMed |
| Macrophages and fibrosis: how resident and infiltrating mononuclear phagocytes account for organ injury, regeneration or atrophy. | Front Immunol | 2023 | 37868987 | PubTator, text mining | PubMed |
| Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in an Elderly Female: A Rare Case. | J Community Hosp Intern Med Perspect | 2023 | 37868236 | PubTator, text mining | PubMed |
| Infections in Patients with Systemic Lupus Erythematosus: The Contribution of Primary Immune Defects Versus Treatment-Induced Immunosuppression. | Eur J Rheumatol | 2023 | 37850609 | PubTator, text mining | PubMed |
| Decoding the immune landscape following hip fracture in elderly patients: unveiling temporal dynamics through single-cell RNA sequencing. | Immun Ageing | 2023 | 37848979 | PubTator, text mining | PubMed |
| Single-cell chromatin accessibility and transcriptomic characterization of Behcet's disease. | Commun Biol | 2023 | 37848613 | PubTator, text mining | PubMed |
| [Chemotherapy Combined with Venetoclax Followed by Allo-Hematopoietic Stem Cell Transplantation for Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2023 | 37846712 | PubTator, text mining | PubMed |
| Phospholipase D4 as a signature of toll-like receptor 7 or 9 signaling is expressed on blastic T-bet + B cells in systemic lupus erythematosus. | Arthritis Res Ther | 2023 | 37840148 | PubTator, text mining | PubMed |
| Blood Immune Cells as Biomarkers in Long-Term Surviving Patients with Advanced Non-Small-Cell Lung Cancer Undergoing a Combined Immune/Chemotherapy. | Cancers (Basel) | 2023 | 37835567 | PubTator, text mining | PubMed |
| The Dual Role of the Innate Immune System in the Effectiveness of mRNA Therapeutics. | Int J Mol Sci | 2023 | 37834268 | PubTator, text mining | PubMed |
| Orbital inflammatory pseudotumor: new advances in diagnosis, pathogenesis, and treatment. | Eur J Med Res | 2023 | 37794419 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/170482/papers?page=7